Global Cancer Cachexia Market Worth $2.85 Billion by 2029: Combination Therapies Gaining Traction
20 mars 2024 11h13 HE
|
Research and Markets
Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. This research report sheds light...
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
23 janv. 2024 08h19 HE
|
Biomerica, Inc.
Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully built...
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
18 déc. 2023 07h47 HE
|
Biomerica, Inc.
Over 80% of gastric cancers are attributed to H. pylori bacterial infection Gastric cancer is the third most common cause of cancer related death in the world ...
Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
22 août 2023 15h56 HE
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results...
Global Gastrointestinal Diagnostics Market to 2030: Increasing Prevalence of Gastrointestinal Disorders Drives Growth
04 avr. 2023 11h04 HE
|
Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Gastrointestinal Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Endoscopy, Blood Test), by Technology, by Application, by...
Gastric Cancer Diagnostic Procedure Market Size Forecasts at 6.5% CAGR during (2022-2028) - Deep Dive Analysis of 18+ Countries across 5 Key Regions, 50+ Companies Scrutinized | The Insight Partners
02 mars 2023 09h55 HE
|
The Insight Partners
New York, March 02, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Gastric Cancer Diagnostic Procedure Market Size, Share, Growth, Trends and Global Forecasts to 2028 - COVID-19 Impact...
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™
12 mai 2022 08h19 HE
|
Biomerica, Inc.
- Attaining CE Mark is a major step toward commercialization – - World Health Organization (WHO) lists H. pylori among the 16 antibiotic-resistant bacteria that pose the greatest threat to human...
Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population
26 avr. 2022 08h19 HE
|
Biomerica, Inc.
Gastric cancer is the third most common cause of cancer related death in the world and over 80% of gastric cancers are attributed to H. pylori bacterial infection H. pylori infection is also a major...
Cancer Advances, Inc. Announces Publication, "Gastrin Vaccine Alone and in Combination with an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer" in Frontiers in Oncology
06 déc. 2021 10h00 HE
|
Cancer Advances Inc
DURHAM, N.C., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces a new publication in...
Tyrokinse Kinase Inhibitors in the Global Oncology Market 2021: Market Leaders by Indication and Product
05 nov. 2021 05h58 HE
|
Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Oncology Markets for Tyrokinse Kinase Inhibitors" report has been added to ResearchAndMarkets.com's offering. Traditional cancer therapy has focused...